Clinical trial · Interventional
Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection
NCT05267041CI-TRIAL-00097735ULYSSErecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sample | Biological | — | UNRESOLVED |
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Cohort of Adults with lung cancer
- description
- Patients newly diagnosed with lung cancer.
- interventionNames
- Biological: Blood sample
- Other: Questionnaire
Primary outcomes (1)
- measure
- Number of participants registered in the lung cancer database
- timeFrame
- 20 years
- description
- cohort open to recruitment during 10 years with 10 years of patients follow-up
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:
* Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma…
* Diagnosis can be done:
* By cytology or pathologic assessment
* Or by multidisciplinary team meeting decision:
* Irradiation without morpho-metabolic sampling
* Treatment without sampling based on non-invasive molecular data
Exclusion Criteria:
\- Refusal to participate
For optional blood sampling :
* \< 30 kg for blood collection
* No blood sampling schedule for careReferences
Publications (0)
Data not yet available
No reference posted for this study.